CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
CTIC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.53%170.200.7%$964.07m
ABBVAbbVie, Inc. 1.67%140.341.9%$841.79m
PFEPfizer Inc. 0.61%49.570.9%$830.12m
LLYEli Lilly & Co. 0.39%302.501.1%$749.11m
MRKMerck & Co., Inc. 1.24%88.490.7%$749.03m
BMYBristol-Myers Squibb Co. 2.33%73.801.0%$664.96m
SIGASIGA Technologies, Inc. -4.76%22.190.0%$393.19m
AZNAstraZeneca Plc -1.38%65.121.0%$376.21m
ALNYAlnylam Pharmaceuticals, Inc. 5.56%230.748.1%$254.69m
GSKGSK Plc -0.64%40.310.3%$216.46m
HZNPHorizon Therapeutics Plc 0.07%69.655.4%$197.93m
SGENSeagen Inc. 1.43%178.335.7%$191.45m
NVSNovartis AG 0.43%85.940.2%$174.13m
RGENRepligen Corp. 1.70%250.466.7%$158.40m
NVONovo Nordisk A/S -0.76%102.420.1%$151.74m

Company Profile

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.